Gene · 6372
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunobiology of the biliary tract system. | J Hepatol | 2022 | 36116989 | PubTator, text mining | PubMed |
| Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective. | Signal Transduct Target Ther | 2022 | 36115852 | PubTator, text mining | PubMed |
| COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy. | Front Med (Lausanne) | 2022 | 36111104 | PubTator, text mining | PubMed |
| O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer. | Pathol Oncol Res | 2022 | 36110252 | PubTator, text mining | PubMed |
| The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy. | Front Endocrinol (Lausanne) | 2022 | 36093115 | PubTator, text mining | PubMed |
| Neutrophils: Musketeers against immunotherapy. | Front Oncol | 2022 | 36091114 | PubTator, text mining | PubMed |
| Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort study. | Alzheimers Res Ther | 2022 | 36085081 | PubTator, text mining | PubMed |
| The Response of the Human Umbilical Vein Endothelial Cell Transcriptome to Variation in Magnesium Concentration. | Nutrients | 2022 | 36079843 | PubTator, text mining | PubMed |
| The CDK1-Related lncRNA and CXCL8 Mediated Immune Resistance in Lung Adenocarcinoma. | Cells | 2022 | 36078096 | PubTator, text mining | PubMed |
| Osteogenic Efficacy of Human Trophoblasts-Derived Conditioned Medium on Mesenchymal Stem Cells. | Int J Mol Sci | 2022 | 36077594 | PubTator, text mining | PubMed |
| Immunomodulatory Drugs in the Treatment of Hidradenitis Suppurativa-Possibilities and Limitations. | Int J Mol Sci | 2022 | 36077114 | PubTator, text mining | PubMed |
| Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid. | Cell Mol Biol Lett | 2022 | 36064322 | PubTator, text mining | PubMed |
| Multi-omics characterization reveals the pathogenesis of liver focal nodular hyperplasia. | iScience | 2022 | 36060063 | PubTator, text mining | PubMed |
| Exploring the pathogenesis of diabetic kidney disease by microarray data analysis. | Front Pharmacol | 2022 | 36059966 | PubTator, text mining | PubMed |
| Macrophage polarization regulates intervertebral disc degeneration by modulating cell proliferation, inflammation mediator secretion, and extracellular matrix metabolism. | Front Immunol | 2022 | 36059551 | PubTator, text mining | PubMed |
| Comprehensive analysis of key genes and pathways for biological and clinical implications in thyroid-associated ophthalmopathy. | BMC Genomics | 2022 | 36056316 | PubTator, text mining | PubMed |
| Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases. | World J Gastroenterol | 2022 | 36051338 | PubTator, text mining | PubMed |
| Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment. | Front Endocrinol (Lausanne) | 2022 | 36046791 | PubTator, text mining | PubMed |
| Whole-transcriptome analysis of periodontal tissue and construction of immune-related competitive endogenous RNA network. | BMC Oral Health | 2022 | 36045361 | PubTator, text mining | PubMed |
| OXTRHigh stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling. | Nat Commun | 2022 | 36045118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6372/papers?page=39